Pacira Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
24.09.24
/
50%
€12.60
Target price
24.09.25
€16.13
Performance (%)
73.02%
End price
25.09.25
€21.80
Summary
This prediction ended on 25.09.25 with a price of €21.80. With a performance of 73.02% the BUY prediction by Jefferies_Financial_ was a big success. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | -5.660% | -5.660% | -3.846% |
| iShares Core DAX® | 0,44 % | 5,64 % | 7,81 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % | 27,24 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % | 49,27 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 22,34 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten